Clinical Trial

Bufei Yishen Prescription on Patients With Frequent AECOPD in Stable Stage

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 22, 2024 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the clinical efficacy and health economic advantages of Lung Replenishing and Kidney Enhancing Formula for the treatment of patients with frequent acute exacerbations in the stabilized phase.
Trial Details
NCT Number NCT06326658
Lead Sponsor Henan University of Traditional Chinese Medicine
Collaborators: The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 848 participants
Start Date 2024-04-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-22